Human pancreatic islet preparations release HMGB1: (Ir)relevance for graft engraftment

Cell Transplantation

Volumn 22, Issue 11, 2013, Pages 2175-2186

  Nano, Rita ^a   Racanicchi, Leda ^a   Melzi, Raffaella ^a   Mercalli, Alessia ^a   Maffi, Paola ^a   Sordi, Valeria ^a   Ling, Zhidong ^b   Scavini, Marina ^a   Korsgren, Olle ^c   Celona, Barbara ^a   Secchi, Antonio ^a,d   Piemonti, Lorenzo ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c UPPSALA UNIVERSITY   (Sweden)

^d VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Engraftment; High mobility group box 1 (HMGB1); Human; Islet transplantation

Indexed keywords

COLLAGENASE; CXCL1 CHEMOKINE; CXCL9 CHEMOKINE; FIBRIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 9; CHEMOKINE; CYTOKINE; FIBRIN DEGRADATION PRODUCT; TOLL LIKE RECEPTOR;

ADULT; ARTICLE; DIGESTION; ENGRAFTMENT; FEMALE; GRAFT FAILURE; HUMAN; HUMAN TISSUE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; PANCREAS; PANCREAS ISLET; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; ALLOTRANSPLANTATION; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CYTOLOGY; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; METABOLISM; MIDDLE AGED;

ADULT; CELLS, CULTURED; CHEMOKINES; CYTOKINES; DIABETES MELLITUS, TYPE 2; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HMGB1 PROTEIN; HUMANS; INTERLEUKIN-1BETA; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MIDDLE AGED; TOLL-LIKE RECEPTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84884586957     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368912X657783     Document Type: Article

References (35)

1. Andrassy, M.; Volz, H. C.; Igwe, J. C.; Funke, B.; Eichberger, S. N.; Kaya, Z.; Buss, S.; Autschbach, F.; Pleger, S. T.; Lukic, I. K.; Bea, F.; Hardt, S. E.; Humpert, P. M.; Bianchi, M. E.; Mairbaurl, H.; Nawroth, P. P.; Remppis, A.; Katus, H. A.; Bierhaus, A. High-mobility group box-1 in ischemiareperfusion injury of the heart. Circulation 117:3216-3226; 2008
2. Bertuzzi, F.; Marzorati, S.; Maffi, P.; Piemonti, L.; Melzi, R.; de Taddeo, F.; Valtolina, V.; D'Angelo, A.; di Carlo, V.; Bonifacio, E.; Secchi, A. Tissue factor and CCL2/monocyte chemoattractant protein-1 released by human islets affect islet engraftment in type 1 diabetic recipients. J. Clin. Endocrinol. Metab. 89:5724-5728; 2004
3. Bianchi, M. E.; Manfredi, A. A. High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity. Immunol. Rev. 220:35-46; 2007
4. Caumo, A.; Maffi, P.; Nano, R.; Bertuzzi, F.; Luzi, L.; Secchi, A.; Bonifacio, E.; Piemonti, L. Transplant estimated function: A simple index to evaluate b-cell secretion after islet transplantation. Diabetes Care 31:301-305; 2008
5. Caumo, A.; Maffi, P.; Nano, R.; Luzi, L.; Hilbrands, R.; Gillard, P.; Jacobs-Tulleneers-Thevissen, D.; Secchi, A.; Keymeulen, B.; Pipeleers, D.; Piemonti, L. Comparative evaluation of simple indices of graft function after islet transplantation. Transplantation 92:815-821; 2011
6. Chavakis, E.; Hain, A.; Vinci, M.; Carmona, G.; Bianchi, M. E.; Vajkoczy, P.; Zeiher, A. M.; Chavakis, T.; Dimmeler, S. High-mobility group box 1 activates integrin-dependent homing of endothelial progenitor cells. Circ. Res. 100:204-212; 2007
7. Dumitriu, I. E.; Baruah, P.; Valentinis, B.; Voll, R. E.; Herrmann, M.; Nawroth, P. P.; Arnold, B.; Bianchi, M. E.; Manfredi, A. A.; Rovere-Querini, P. Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products. J. Immunol. 174:7506-7515; 2005
8. Gauley, J.; Pisetsky, D. S. The translocation of HMGB1 during cell activation and cell death. Autoimmunity 42: 299-301; 2009
9. Ito, T.; Kawahara, K.; Nakamura, T.; Yamada, S.; Nakamura, T.; Abeyama, K.; Hashiguchi, T.; Maruyama, I. High-mobility group box 1 protein promotes development of microvascular thrombosis in rats. J. Thromb. Haemost. 5:109-116; 2007
10. Itoh, T.; Iwahashi, S.; Shimoda, M.; Chujo, D.; Takita, M.; So Relle, J. A.; Naziruddin, B.; Levy, M. F.; Matsumoto, S. High-mobility group box 1 expressions in hypoxia-induced damaged mouse islets. Transplant. Proc. 43:3156-3160; 2011
11. Johansson, H.; Lukinius, A.; Moberg, L.; Lundgren, T.; Berne, C.; Foss, A.; Felldin, M.; Kallen, R.; Salmela, K.; Tibell, A.; Tufveson, G.; Ekdahl, K. N.; Elgue, G.; Korsgren, O.; Nilsson, B. Tissue factor produced by the endocrine cells of the islets of langerhans is associated with a negative outcome of clinical islet transplantation. Diabetes 54:1755-1762; 2005
12. Kokkola, R.; Andersson, A.; Mullins, G.; Ostberg, T.; Treutiger, C. J.; Arnold, B.; Nawroth, P.; Andersson, U.; Harris, R. A.; Harris, H. E. RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand. J. Immunol. 61:1-9; 2005
13. Kokkola, R.; Sundberg, E.; Ulfgren, A. K.; Palmblad, K.; Li, J.; Wang, H.; Ulloa, L.; Yang, H.; Yan, X. J.; Furie, R.; Chiorazzi, N.; Tracey, K. J.; Andersson, U.; Harris, H. E. High mobility group box chromosomal protein 1: A novel proinflammatory mediator in synovitis. Arthritis Rheum. 46:2598-2603; 2002
14. Kruger, B.; Yin, N.; Zhang, N.; Yadav, A.; Coward, W.; Lal, G.; Zang, W.; S Heeger, P.; Bromberg, J. S.; Murphy, B.; Schroppel, B. Islet-expressed TLR2 and TLR4 sense injury and mediate early graft failure after transplantation. Eur. J. Immunol. 40:2914-2924; 2010
15. Lee, B. W.; Chae, H. Y.; Kwon, S. J.; Park, S. Y.; Ihm, J.; Ihm, S. H. RAGE ligands induce apoptotic cell death of pancreatic b-cells via oxidative stress. Int. J. Mol. Med. 26:813-818; 2010
16. Matsuoka, N.; Itoh, T.; Watarai, H.; Sekine-Kondo, E.; Nagata, N.; Okamoto, K.; Mera, T.; Yamamoto, H.; Yamada, S.; Maruyama, I.; Taniguchi, M.; Yasunami, Y. High-mobility group box 1 is involved in the initial events of early loss of transplanted islets in mice. J. Clin. Invest. 120:735-743; 2010
17. Melzi, R.; Mercalli, A.; Sordi, V.; Cantarelli, E.; Nano, R.; Maffi, P.; Sitia, G.; Guidotti, L. G.; Secchi, A.; Bonifacio, E.; Piemonti, L. Role of CCL2/MCP-1 in islet transplantation. Cell Transplant. 19:1031-1046; 2010
18. Melzi, R.; Piemonti, L.; Nano, R.; Clissi, B.; Calori, G.; Antonioli, B.; Marzorati, S.; Perseghin, G.; Di Carlo, V.; Bertuzzi, F. Donor and isolation variables associated with human islet monocyte chemoattractant protein-1 release. Transplantation 78:1564-1567; 2004
19. Messmer, D.; Yang, H.; Telusma, G.; Knoll, F.; Li, J.; Messmer, B.; Tracey, K. J.; Chiorazzi, N. High mobility group box protein 1: An endogenous signal for dendritic cell maturation and Th1 polarization. J. Immunol. 173:307-313; 2004
20. Moberg, L.; Johansson, H.; Lukinius, A.; Berne, C.; Foss, A.; Kallen, R.; Ostraat, O.; Salmela, K.; Tibell, A.; Tufveson, G.; Elgue, G.; Nilsson Ekdahl, K.; Korsgren, O.; Nilsson, B. Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet 360:2039-2045; 2002
21. Nomura, S.; Fujita, S.; Ozasa, R.; Nakanishi, T.; Miyaji, M.; Mori, S.; Ito, T.; Ishii, K. The correlation between platelet activation markers and HMGB1 in patients with disseminated intravascular coagulation and hematologic malignancy. Platelets 22:396-397; 2011
22. Park, J. S.; Svetkauskaite, D.; He, Q.; Kim, J. Y.; Strassheim, D.; Ishizaka, A.; Abraham, E. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J. Biol. Chem. 279:7370-7377; 2004
23. Penzo, M.; Molteni, R.; Suda, T.; Samaniego, S.; Raucci, A.; Habiel, D. M.; Miller, F.; Jiang, H. P.; Li, J.; Pardi, R.; Palumbo, R.; Olivotto, E.; Kew, R. R.; Bianchi, M. E.; Marcu, K. B. Inhibitor of NF-kB kinases a and b are both essential for high mobility group box 1-mediated chemotaxis. J. Immunol. 184:4497-4509; 2010
24. Piemonti, L.; Guidotti, L. G.; Battaglia, M. Modulation of early inflammatory reactions to promote engraftment and function of transplanted pancreatic islets in autoimmune diabetes. Adv. Exp. Med. Biol. 654:725-747; 2010
25. Piemonti, L.; Leone, B. E.; Nano, R.; Saccani, A.; Monti, P.; Maffi, P.; Bianchi, G.; Sica, A.; Peri, G.; Melzi, R.; Aldrighetti, L.; Secchi, A.; Di Carlo, V.; Allavena, P.; Bertuzzi, F. Human pancreatic islets produce and secrete MCP-1/CCL2: Relevance in human islet transplantation. Diabetes 51:55-65; 2002
26. Pipeleers, D. G.; in't Veld, P. A.; Van de Winkel, M.; Maes, E.; Schuit, F. C.; Gepts, W. A new in vitro model for the study of pancreatic A- and B-cells. Endocrinology 117:806-816; 1985
27. Pisetsky, D. S.; Jiang, W. Role of toll-like receptors in HMGB1 release from macrophages. Ann. N. Y. Acad. Sci. 1109:58-65; 2007
28. Rossini, A.; Zacheo, A.; Mocini, D.; Totta, P.; Facchiano, A.; Castoldi, R.; Sordini, P.; Pompilio, G.; Abeni, D.; Capogrossi, M. C.; Germani, A. HMGB1-stimulated human primary cardiac fibroblasts exert a paracrine action on human and murine cardiac stem cells. J. Mol. Cell. Cardiol. 44:683-693; 2008
29. Roussel, B. D.; Mysiorek, C.; Rouhiainen, A.; Jullienne, A.; Parcq, J.; Hommet, Y.; Culot, M.; Berezowski, V.; Cecchelli, R.; Rauvala, H.; Vivien, D.; Ali, C. HMGB-1 promotes fibrinolysis and reduces neurotoxicity mediated by tissue plasminogen activator. J. Cell Sci. 124:2070-2076; 2011
30. Scaffidi, P.; Misteli, T.; Bianchi, M. E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418:191-195; 2002
31. Schiraldi, M.; Raucci, A.; Munoz, L. M.; Livoti, E.; Celona, B.; Venereau, E.; Apuzzo, T.; De Marchis, F.; Pedotti, M.; Bachi, A.; Thelen, M.; Varani, L.; Mellado, M.; Proudfoot, A.; Bianchi, M. E.; Uguccioni, M. HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4. J. Exp. Med. 209:551-563; 2012
32. Shapiro, A. M.; Ricordi, C.; Hering, B. J.; Auchincloss, H.; Lindblad, R.; Robertson, R. P.; Secchi, A.; Brendel, M. D.; Berney, T.; Brennan, D. C.; Cagliero, E.; Alejandro, R.; Ryan, E. A.; DiMercurio, B.; Morel, P.; Polonsky, K. S.; Reems, J. A.; Bretzel, R. G.; Bertuzzi, F.; Froud, T.; Kandaswamy, R.; Sutherland, D. E.; Eisenbarth, G.; Segal, M.; Preiksaitis, J.; Korbutt, G. S.; Barton, F. B.; Viviano, L.; Seyfert-Margolis, V.; Bluestone, J.; Lakey, J. R. International trial of the Edmonton protocol for islet transplantation. N. Engl. J. Med. 355:1318-1330; 2006
33. Truyen, I.; De Pauw, P.; Jorgensen, P. N.; Van Schravendijk, C.; Ubani, O.; Decochez, K.; Vandemeulebroucke, E.; Weets, I.; Mao, R.; Pipeleers, D. G.; Gorus, F. K.; Belgian Diabetes Registry. Proinsulin levels and the proinsulin: C-peptide ratio complement autoantibody measurement for predicting type 1 diabetes. Diabetologia 48:2322-2329; 2005
34. Wang, H.; Bloom, O.; Zhang, M.; Vishnubhakat, J. M.; Ombrellino, M.; Che, J.; Frazier, A.; Yang, H.; Ivanova, S.; Borovikova, L.; Manogue, K. R.; Faist, E.; Abraham, E.; Andersson, J.; Andersson, U.; Molina, P. E.; Abumrad, N. N.; Sama, A.; Tracey, K. J. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285:248-251; 1999
35. Zhang, S.; Zhong, J.; Yang, P.; Gong, F.; Wang, C. Y. HMGB1, an innate alarmin, in the pathogenesis of type 1 diabetes. Int. J. Clin. Exp. Pathol. 3:24-38; 2009.